Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).

TUGUEGARAO CITY, Cagayan (PIA) — PhilHealth has expanded its benefit package for the treatment of ischemic heart disease or acute myocardial infarction, commonly known as heart attack, one of the ...

PhilHealth has significantly increased its coverage for Ischemic Heart Disease-Acute Myocardial Infarction (IHD-AMI) or ...

A research team led by Matthew Nystoriak, Ph.D., associate professor of biomedical research and translational medicine at ...

AS Filipinos celebrate the holiday season, the Department of Health recently called on people to prioritize their well-being ...

The research highlights how a ketone body called β-hydroxybutyrate (3-OHB) — a molecule produced by the liver when breaking ...

The Philippine Health Insurance Corporation (PhilHealth) on Friday announced a significant expansion of its benefits package ...